EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines

Gladson, 1999, The extracellular matrix of gliomas: modulation of cell function, J Neuropathol Exp Neurol, 58, 1029, 10.1097/00005072-199910000-00001 Goldbrunner, 1999, Cell-extracellular matrix interaction in glioma invasion, Acta Neurochir (Wien), 141, 295, 10.1007/s007010050301 Paulus, 1995, Interactions of glioma cells and extracellular matrix, J Neurooncol, 24, 87, 10.1007/BF01052664 Ariza, 1995, Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study, Hum Pathol, 26, 1144, 10.1016/0046-8177(95)90278-3 Goldbrunner, 1998, ECM-mediated glioma cell invasion, Microsc Res Tech, 43, 250, 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C Okada, 1996, Suppression of CD44 expression decreases migration and invasion of human glioma cells, Int J Cancer, 66, 255, 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A Gunia, 1999, CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma, Clin Exp Metastasis, 17, 221, 10.1023/A:1006699203287 Merzak, 1994, CD44 mediates human glioma cell adhesion and invasion in vitro, Cancer Res, 54, 3988 Wiranowska, 1998, The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro, Anticancer Res, 18, 3331 Khoshyomn, 1997, Localisation of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy, Ultrastruct Pathol, 21, 517, 10.3109/01913129709016368 Bajorath, 2000, Molecular organisation, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions, Proteins, 39, 103, 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.0.CO;2-G Fraser, 1997, Hyaluronan: its nature, distribution, functions and turnover, J Intern Med, 242, 27, 10.1046/j.1365-2796.1997.00170.x Laurent, 1992, Hyaluronan, FASEB J, 6, 2397, 10.1096/fasebj.6.7.1563592 Chen, 1999, Functions of hyaluronan in wound repair, Wound Repair Regen, 7, 79, 10.1046/j.1524-475X.1999.00079.x Toole, 1997, Hyaluronan in morphogenesis, J Intern Med, 242, 35, 10.1046/j.1365-2796.1997.00171.x Delpech, 1997, Hyaluronan: fundamental principles and applications in cancer, J Intern Med, 242, 41, 10.1046/j.1365-2796.1997.00172.x Delpech, 1993, Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma, Eur J Cancer, 29A, 1012, 10.1016/S0959-8049(05)80214-X Antilla, 2000, High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer, Cancer Res, 60, 150 Steck, 1989, Altered expression and distribution of heparan sulfate proteoglycans in human gliomas, Cancer Res, 49, 2096 Bartolazzi, 1994, Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development, J Exp Med, 180, 53, 10.1084/jem.180.1.53 Koocheckpour, 1995, Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro, Int J Cancer, 63, 450, 10.1002/ijc.2910630325 Radotra, 1997, Glioma cell invasion in vitro is mediated by CD44-hyaluronan interactions, J Pathol, 181, 434, 10.1002/(SICI)1096-9896(199704)181:4<434::AID-PATH797>3.0.CO;2-S Novak, 1999, Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells, Cancer Res, 59, 6246 Deed, 1997, Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells, Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer, 71, 251 Rooney, 1995, The role of hyaluronan in tumour neovascularization (review), Int J Cancer, 60, 632, 10.1002/ijc.2910600511 Slevin, 1998, Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation, Lab Invest, 78, 987 Libermann, 1985, Amplification and overexpression of the EGF receptor gene in primary human glioblastomas, J Cell Sci Suppl, 3, 161, 10.1242/jcs.1985.Supplement_3.16 Schlegel, 1994, Amplification and differential expression of members of the erbB-gene family in human glioblastomas, J Neurooncol, 22, 201, 10.1007/BF01052920 Chaffanet, 1992, EGF receptor amplification and expression in human brain tumors, Eur J Cancer, 28, 11, 10.1016/0959-8049(92)90374-B Libermann, 1985, Amplification, enhanced expression and possible rearrangements of EGF receptor gene is primary human brain tumors of glial origin, Nature, 313, 144, 10.1038/313144a0 Nagane, 1996, A common mutant epidermal growth factor receptor confers enhanced tumorigenecity on human glioblastoma cells by increasing proliferation and reducing apoptosis, Cancer Res, 56, 5079 Scwechheimer, 1994, Expression of neu/c-erbB-2 in human brain tumors, Hum Pathol, 25, 772, 10.1016/0046-8177(94)90246-1 Bourguignon, 1997, Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation, J Biol Chem, 272, 27913, 10.1074/jbc.272.44.27913 Sherman, 2000, CD44 enhances neuregulin signaling by Schwann cells, J. Cell Biol, 150, 1071, 10.1083/jcb.150.5.1071 Nishikawa, 1994, A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity, Proc Natl Acad Sci USA, 91, 7727, 10.1073/pnas.91.16.7727 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thoicyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 Dougall, 1993, Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy, J Cell Biochem, 53, 61, 10.1002/jcb.240530108 Earp, 1995, Heterodimerization and functional interaction between EGF receptor family members: a new signalling paradigm with implications for breast cancer research, Breast Cancer Res Treat, 35, 115, 10.1007/BF00694752 Qian, 1994, Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: A mechanism of interreceptor kinase activation and transphosphorylation, Proc Natl Acad Sci USA, 91, 1500, 10.1073/pnas.91.4.1500 Seger, 1995, The MAPK signalling cascade, FASEB J, 9, 726, 10.1096/fasebj.9.9.7601337 Nakagawa, 1996, Hyaluronic acid facilitates glioma cell invasion in vitro, Anticancer Res, 16, 2917 West, 1989, The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity, Exp Cell Res, 183, 179, 10.1016/0014-4827(89)90428-X Fitzgerald, 2000, Ras, protein kinase Cζ, and IκB kinases are downstream effectors of CD44 during the activation of NF-κB by hyaluronic acid fragments in T-24 carcinoma cells, J Immunol, 164, 2053, 10.4049/jimmunol.164.4.2053 McKee, 1997, Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism, J Biol Chem, 272, 8013, 10.1074/jbc.272.12.8013 Descheemaeker, 1992, Interaction of AP-1-, AP-2-, and Sp-1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response, J Biol Chem, 267, 15086, 10.1016/S0021-9258(18)42149-7 D'Orazio, 1997, Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2, Gene, 201, 179, 10.1016/S0378-1119(97)00445-9 Logan, 1996, Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via the functional interaction of AP-1 and Ets-1 transcription factors, J Biol Chem, 271, 774, 10.1074/jbc.271.2.774 Mohanam, 1999, Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo, Int J Oncol, 14, 169 Yamamoto, 1994, Expression and localisation of urokinase-type plasminogen activator receptor in human gliomas, Cancer Res, 54, 5016 Nguyen, 1998, Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility, J Biol Chem, 273, 8502, 10.1074/jbc.273.14.8502 Tang, 1998, The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells, J Biol Chem, 273, 18268, 10.1074/jbc.273.29.18268 Dumler, 1998, The Jak/Stat pathway and urokinase receptor signalling in human aortic vascular smooth muscle cells, J Biol Chem, 273, 315, 10.1074/jbc.273.1.315